|
Chen, Kevin G; Sikic, Branimir I (2012) Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 18:1863-9
|
|
Galatin, Peter S; Advani, Ranjana H; Fisher, George A et al. (2011) Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies. Invest New Drugs 29:971-7
|
|
O'Brien, Maureen M; Lacayo, Norman J; Lum, Bert L et al. (2010) Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer 54:694-702
|
|
Fisher, George A; Kuo, Timothy; Ramsey, Meghan et al. (2008) A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer. Clin Cancer Res 14:7074-9
|
|
Cho, Cheryl D; Fisher, George A; Halsey, Joanne et al. (2006) Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies. Invest New Drugs 24:117-23
|
|
Kuo, Timothy; Cho, Cheryl D; Halsey, Joanne et al. (2005) Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer. J Clin Oncol 23:5613-9
|
|
Advani, Ranjana; Lum, Bert L; Fisher, George A et al. (2005) A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer. Invest New Drugs 23:467-77
|
|
Advani, R; Lum, B L; Fisher, G A et al. (2005) A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance. Ann Oncol 16:1968-73
|
|
Advani, Ranjana; Peethambaram, Prema; Lum, Bert L et al. (2004) A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma. Cancer 100:321-6
|
|
Greenberg, Peter L; Lee, Sandra J; Advani, Ranjana et al. (2004) Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995). J Clin Oncol 22:1078-86
|
Showing the most recent 10 out of 46 publications
